---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-031862"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:29:44.124824+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Abeona Therapeutics appoints Drs. Zeiher and Crombez to Board of Directors

## Summary
- Bernhardt G. Zeiher, MD appointed as Class 1 director; Eric Crombez, MD as Class 2 director; both independent.
- Zeiher is former CMO of Astellas Pharma with 20+ years of drug development; Crombez is CMO of Ultragenyx and FDA advisory committee member.
- Each director receives $50,000 annual cash retainer and $55,000 one-time RSAs with one-year vesting.
- Appointments effective August 8, 2024 (Zeiher) and August 12, 2024 (Crombez).
- Additions come as Abeona focuses on pz-cel gene therapy for RDEB and pipeline expansion.

## SEC filing metadata
- accession: 0001493152-24-031862
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315224031862/0001493152-24-031862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315224031862/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-031862
- JSON: https://secwatch.observer/filing/0001493152-24-031862.json
- Plain text: https://secwatch.observer/filing/0001493152-24-031862.txt

## Key facts
- Executive change
  Eric Crombez was appointed as Director at ABEONA THERAPEUTICS INC..
  - Action: appointed
  - Role: Director
  source text: appointed Bernhardt G. Zeiher, MD, FCCP, FACP, on August 8, 2024 and Eric Crombez, MD on August 12, 2024 as members of the Board of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224031862/0001493152-24-031862-index.htm
- Executive change
  Bernhardt G. Zeiher was appointed as Director at ABEONA THERAPEUTICS INC..
  - Action: appointed
  - Role: Director
  source text: appointed Bernhardt G. Zeiher, MD, FCCP, FACP, on August 8, 2024 and Eric Crombez, MD on August 12, 2024 as members of the Board of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224031862/0001493152-24-031862-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.